Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions:: The ECTIM study

被引:14
作者
Brousseau, T
Dupuy-Gorce, AM
Evans, A
Arveiler, D
Ruidavets, JB
Haas, B
Cambou, JP
Luc, G
Ducimetière, P
Amouyel, P
Helbecque, N
机构
[1] Inst Pasteur, INSERM, U508, F-59019 Lille, France
[2] Univ Lille 2, Lille, France
[3] Inst Biol, Lab Biol A, Montpellier, France
[4] Queens Univ Belfast, Belfast MONICA Project, Belfast, Antrim, North Ireland
[5] Fac Med Strasbourg, Strasbourg MONICA Project, Strasbourg, France
[6] INSERM, U518, Fac Med Toulouse Purpan, Toulouse, France
[7] Inst Pasteur, INSERM, U545, F-59019 Lille, France
[8] Hop Paul Brousse, INSERM, U258, Villejuif, France
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 110卷 / 01期
关键词
APOA-II gene; (CA)(n)-repeat polymorphism; lipoproteins;
D O I
10.1002/ajmg.10364
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
High density lipoproteins (HDL) are heterogeneous in their apolipoprotein composition and the role of apolipoprotein A-II (APOA-II) in HDL structure and metabolism is poorly understood. Yet, studies of naturally occurring variations of APOA-II in mice and experiments in transgenic mice overexpressing the APOA-II gene (APOA-II) have shown that APOA-II expression influences APOA-II plasma levels and HDL size and composition. In humans, two RFLPs (BstNI and MspI) have been described in the APOA-II gene. These RFLPs, however, have been inconstantly associated with variations in APOA-II plasma levels. In particular, the large multicentric ECTIM Study did not show any significant effect of the two RFLPs. Other polymorphisms consisting of repetitive sequences have been proposed as more informative markers than RFLPs. Thus, data from the ECTIM Study were reconsidered by integrating the additional information obtained from a highly informative multiallelic (CA)(n)-repeat polymorphism located in the second intron of the gene. The population study was composed of 763 non-treated male controls and 594 cases of myocardial infarction. In controls, the (CA)(19) allele was associated with significantly decreased APOA-II (P < 0.0009) and LpA-II:A-I (P < 0.02) plasma levels. Although the APOA-I plasma levels were not affected by the polymorphism, the (CA)19 allele was associated with an increased LpA-I/LpA-II:A-I ratio (P < 0.004). No effect, however, could be detected on myocardial infarction. Study of the linkage disequilibrium and the estimation of haplotype frequencies indicated that the impact of the APOA-II locus could hardly be detected by using the BstNI and MspI RFLPs. These data revive interest in evaluating the role of the APOA-II locus in the control of APOA-II plasma levels and HDL composition. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 44 条
[1]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[2]   THE MSPI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM 3' TO THE APOLIPOPROTEIN-A-II GENE - RELATIONSHIPS WITH LIPIDS, APOLIPOPROTEINS, AND PREMATURE CORONARY-ARTERY DISEASE [J].
CIVEIRA, F ;
GENEST, J ;
POCOVI, M ;
SALEM, DN ;
HERBERT, PN ;
WILSON, PWF ;
SCHAEFER, EJ ;
ORDOVAS, JM .
ATHEROSCLEROSIS, 1992, 92 (2-3) :165-176
[3]  
COX NJ, 1988, AM J HUM GENET, V43, P495
[4]  
DOOLITTLE MH, 1990, J BIOL CHEM, V265, P10380
[5]  
DupuyGorce AM, 1996, CLIN GENET, V50, P191
[6]   ELONGATION AND MATURATION OF C-MYC RNA IS INHIBITED BY DIFFERENTIATION INDUCING AGENTS IN HL60 CELLS [J].
EICK, D .
NUCLEIC ACIDS RESEARCH, 1990, 18 (05) :1199-1205
[7]  
Escolà-Gil JC, 2000, J LIPID RES, V41, P1328
[8]  
ESCOLAGIL JJ, 2000, BIOCHIM BIOPHYS ACTA, V15, P233
[9]  
FERNS GAA, 1986, HUM GENET, V74, P302
[10]  
FIELDING CJ, 1995, J LIPID RES, V36, P211